Work

Efficacy Results of a Phase 2 Trial Evaluating Idelalisib Plus Ofatumumab in Patients with Previously Untreated Chronic Lymphocytic Leukemia

Year: 2017

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v130.suppl_1.1734.1734

Authors: Benjamin L. Lampson, Haesook T. Kim, Matthew S. Davids, Jeremy S. Abramson, Arnold S. Freedman, Caron A. Jacobson, Philippe Armand, Robin Joyce, Jon Arnason, Laura Z. Rassenti, Thomas J. Kipps, Samantha Huang, Joshua Fein, John Hanna, Stacey M. Fernandes, David C. Fisher, Jennifer R. Brown

Institutions: Dana-Farber Cancer Institute, Massachusetts General Hospital, Beth Israel Deaconess Medical Center, Harvard University, University of California San Diego, Moores Cancer Center

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3132404807

FWCI: 0.77

Cites:

Cited by: 5

Related to: 10